< em > BCAT1 < /em > , < em > IKZF1 < /em > and < em > SEPT9 < /em > : methylated DNA biomarkers for detection of pan-gastrointestinal adenocarcinomas
DISCUSSION: Existing CRC methylated ctDNA blood tests for BCAT1/IKZF1 and SEPT9 might be usefully repurposed for use in other gastrointestinal adenocarcinomas and warrant further prospective ctDNA studies.PMID:38644767 | DOI:10.1080/1354750X.2024.2340663
Source: Biomarkers - Category: Research Authors: Geraldine Laven-Law Ganessan Kichenadasse Graeme P Young Erin L Symonds Jean M Winter Source Type: research
More News: Adenocarcinoma | Bile Duct Cancer | Cancer | Cancer & Oncology | Cholangiocarcinoma | Colorectal Cancer | Gastroenterology | Pancreas | Pancreatic Cancer | Research | Study